celares GmbH

General information
celares GmbH
Robert-Roessle-Str. 10
Gebäude D80
13125 Berlin, Berlin
Germany

Contact person: Ralf Krähmer, CSO and Business Development
Company main phone: +49 (30) 94 89 23 50
Company main fax:  +49 (30) 94 89 23 51
Website:  www.celares.com
Year founded:2003
Source of foundation:Independent foundation
No. of employees: Worldwide:  20
At this location:  19
Corporate description / mission:
celares GmbH is an established conjugation and drug delivery company which provides customized solutions. The company develops and produces new, biocompatible drug delivery systems that are based on polyethylene glycol and other amphiphilic polymers.
Moreover, celares is a technology provider for multiplexing of large and small molecules with own IP. The technologies are ready for out-licensing.
State of ownership: Private / independent
Headquarters: Yes
Categorization
Sector:
  • Biotechnology - R&D Services
Subsector:
  • Analytical services
  • CRO (Contract Research Organization)
  • Diagnostic services
  • Drug delivery
  • Synthesis services
Business model:
  • Out-licensing
  • R&D
  • Research on contract basis
  • Service company
Customer segments:
  • Large biotech & big pharma
  • Small biotech
Summary Products / Services / Technologies
Description of products:
- Process development for production of conjugated drugs
- Development and validation of analytical
methods
- Supply of conjugated drugs for in-vitro and
animal studies
- Synthesis of tailor-made PEG, Linker and polymers
- Synthesis of Linker-Drug conjugates for ADC development
- GMP production of activated PEG
Special IP situation:
IP in multiplexing technologies:
a) PaSmax® particular for multiplexing small-molecules, such as drugs to attach them to antibodies
b) celaSTAR particular for multiplexing large molecules to make use of a strong multivalence effect
Collaborations & Clients
Partnering strategy / collaborations:
modular collaboration agreements, e.g. feasibility study, product and process development, contract manufacturing, anayltical services.
Client portfolio (as relevant):
small and large biotech and pharma; drug delivery specialists; diagnostic companies
X